Can you help me interpreting these medical reports (first time here)
Hello to everyone, first time here (M, 33)
I'm gonna share here my blood analysis and scintigrafy, I'd be glad if someone who is more expert than me (easy, I don't know almost nothing about this) about the topic to give some advice, hints, guide, clearing common misurunderstanding etc
Thank you in advance for your time and effort!
----
| Test | Result | Unit | Reference Range |
|---|---|---|---|
| Creatinine | 0.84 | mg/dL | 0.70 – 1.20 |
| Estimated Glomerular Filtration Rate (eGFR) | > 90 | mL/min/1.73 m² | — |
| Total Proteins | 7.6 | g/dL | 6.0 – 8.0 |
| Calcium | 9.5 | mg/dL | 8.4 – 10.2 |
| Phosphorus | 3.3 | mg/dL | 2.5 – 4.5 |
| Total 25-OH Vitamin D | 4 | ng/mL | Increased risk of deficiency: < 12 |
| Increased risk of insufficiency: 12 – 20 | |||
| Sufficiency: 20 – 50 | |||
| Increased risk of excess: > 50 |
| Test | Result | Unit | Reference Range |
|---|---|---|---|
| Thyroid-Stimulating Hormone (TSH Ultra-sensitive) | 2.100 | µIU/mL | 0.350 – 4.940 |
| Free Thyroxine (FT4) | 0.99 | ng/dL | 0.70 – 1.48 |
| Parathyroid Hormone (PTH) | 106.3 | pg/mL | 19.3 – 112.5 |
---
Examination Requested
Parathyroid scintigraphy (including thyroid)
Report
Radionuclide: 99mTc
Radiotracer: Sestamibi
Administered Activity: 541 MBq
The scintigraphic examination was performed in two phases:
20 minutes after administration of the radiopharmaceutical
120 minutes after administration of the radiopharmaceutical
Delayed acquisition was supplemented with SPECT/CT imaging.
Diagnostic Question
Suspicion of a left caudal parathyroid adenoma.
Findings
Planar imaging does not demonstrate areas of delayed tracer washout suggestive of hyperplastic parathyroid glands in the neck or mediastinum.
SPECT/CT imaging demonstrates an oval-shaped formation with heterogeneous density, partially and mildly tracer-avid, located caudally to the inferior pole of the left thyroid lobe (approximately 15 mm in size).
Conclusion
Parathyroid finding of uncertain nature
(possible lymphadenopathy versus parathyroid adenoma).
Further diagnostic evaluation with [18F]-Fluorocholine PET/CT is recommended.